- $718.39m
- $529.67m
- 18
- 10
- 87
- 31
Annual income statement for Annexon, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 63.5 | 131 | 146 | 144 | 154 |
| Operating Profit | -63.5 | -131 | -146 | -144 | -154 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -63.4 | -130 | -142 | -134 | -138 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -63.4 | -130 | -142 | -134 | -138 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -63.4 | -130 | -142 | -134 | -138 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -70.3 | -130 | -142 | -134 | -138 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -4.15 | -3.4 | -2.6 | -1.77 | -1.01 |